Page last updated: 2024-09-03

candoxatrilat and bq 123

candoxatrilat has been researched along with bq 123 in 1 studies

Compound Research Comparison

Studies
(candoxatrilat)
Trials
(candoxatrilat)
Recent Studies (post-2010)
(candoxatrilat)
Studies
(bq 123)
Trials
(bq 123)
Recent Studies (post-2010) (bq 123)
461011,39163152

Protein Interaction Comparison

ProteinTaxonomycandoxatrilat (IC50)bq 123 (IC50)
Endothelin-1 receptorHomo sapiens (human)0.017
Endothelin-1 receptorRattus norvegicus (Norway rat)0.014

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ferro, CJ; Haynes, WG; Spratt, JC; Webb, DJ1

Trials

1 trial(s) available for candoxatrilat and bq 123

ArticleYear
Inhibition of neutral endopeptidase causes vasoconstriction of human resistance vessels in vivo.
    Circulation, 1998, Jun-16, Volume: 97, Issue:23

    Topics: Adult; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Blood Pressure; Coronary Vessels; Cross-Over Studies; Cyclohexanecarboxylic Acids; Enalapril; Endothelin-1; Humans; Hypertension; Injections, Intra-Arterial; Male; Middle Aged; Myocardium; Neprilysin; Peptides, Cyclic; Protease Inhibitors; Renin; Single-Blind Method; Thiorphan; Vasoconstriction

1998